Status:
UNKNOWN
Comparison of Stellaris Standard Infusion With Stellaris Elite
Lead Sponsor:
Prim. Prof. Dr. Oliver Findl, MBA
Conditions:
Cataract
Eligibility:
All Genders
21-105 years
Phase:
NA
Brief Summary
Clinical performance of phacoemulsification platform Stellaris Elite with standard irrigation fluid bottles in myopic eyes. Anterior chamber depth and patients comfort will be compared between the two...
Detailed Description
Today phacoemulsification is the most important and safest procedure to perform cataract surgery. However, there are factors that can increase the risk of complications, one of them is an intraoperati...
Eligibility Criteria
Inclusion
- Age-related cataract in both eyes
- Scheduled for bilateral cataract surgery
- Myopic patiens with axial eye length \>25.0mm
- Age 21 and older
- Written informed consent prior to recruitment
Exclusion
- Pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
- Preceded ophthalmic surgery
- Any ophthalmic abnormality that could compromise the measurements
- Concurrent participation in another drug or device clinical investigation
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03751254
Start Date
October 1 2018
End Date
December 1 2019
Last Update
November 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna Institute for Research in Ocular Surgery (VIROS)
Vienna, Austria, 1140